Buy These 3 Dividend Stocks Today and Thank Yourself in 20 Years
Coca-Cola is performing well in a difficult market, which should attract conservative investors. Gen…
fool.com
GSK(GSK)
GSK
Next earnings: Jul 29, 2026 · Before open
Signal
Bearish Setup2↓
PRICE
Prev Close
52.31
Open
51.80
Day Range51.52 – 52.23
51.52
52.23
52W Range35.45 – 61.70
35.45
61.70
62% of range
VOLUME & SIZE
Avg Volume
5.3M
FUNDAMENTALS
P/E Ratio
13.4x
Value territory
EPS (TTM)
—
Div Yield
0.07%
Beta
0.32
Low vol
Performance
1D
-1.34%5D
-4.80%1M↓
-8.96%3M
-1.64%6M
+10.14%YTD
+5.24%1Y↑
+32.10%Best: 1Y (+32.10%)Worst: 1M (-8.96%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +4% YoY · 73% gross marginValuation
CHEAP
P/E 13x vs ~20x sectorHealth
MODERATE
CR 0.8 (low) · FCF $1.25/shStrong Buy
Key MetricsTTM
Market Cap$75.89B
Revenue TTM$32.78B
Net Income TTM$5.83B
Free Cash Flow$6.24B
Gross Margin72.7%
Net Margin17.8%
Operating Margin22.3%
Return on Equity35.8%
Return on Assets9.3%
Debt / Equity1.07
Current Ratio0.79
EPS TTM$1.45
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 strong2 watch2 concern
59/100Liquidity
0.79Concern
Leverage
1.07Watch
Coverage
10.4xStrong
ROE
35.8%Strong
ROIC
13.8%Watch
Cash
$3.4BConcern
ANALYST COVERAGE29 analysts
HOLD
▲ +2.7%upside to target
L $35.25
Med $53.00consensus
H $85.00Stock Health
Composite Score
1 of 5 signals bullish
4/10
Technicals
●
✗RSI RangeRSI 42 — Bearish momentum
Volume
●
~Volume FlowNeutral
Fundamentals
●
✓Last EarningsBeat estimates
●
~Analyst ConsensusHold
●
✗LiquidityCurrent Ratio 0.79 — liquidity risk
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 17, 2026
In 106 days
FinancialsFull statements →
Technicals
Technical SetupBULLISH
Technicals →Trend
▲ UptrendGolden Cross · 50D leads 200D by 39.1%
+1.5% vs SMA 50 · +41.2% vs SMA 200
Momentum
RSI41.7Momentum fading
MACD+0.92Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$61.70+19.6%
Current
$51.61
EMA 50
$51.45-0.3%
EMA 200
$38.74-24.9%
52W Low
$35.45-31.3%
52-Week RangeMid-range
$35.4562th %ile$61.70
Squeeze SetupVolume-based
No Clear SetupVolume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
20-Day Money Flow
Acc days:4
Dist days:4
Edge:Even
Volume Context
Avg Vol (50D)5.5M
Recent Vol (5D)
8.6M+57%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 14 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $43.6B $43.0B–$44.1B | — | $4.54 | — | ±2% | High12 |
FY2026(current) | $45.7B $45.3B–$46.2B | ▲ +4.6% | $4.84 | ▲ +6.6% | ±2% | High7 |
FY2027 | $48.0B $45.5B–$49.1B | ▲ +5.1% | $5.33 | ▲ +10.2% | ±3% | High14 |
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 7 consecutive quarters
Earnings HistoryGSK
Last 8Q
+10.3%avg beat
Beat 7 of 8 quartersMissed 1↑ Estimates rising-5%
Q1'24
+9%
Q3'24
+9%
Q4'24
+34%
Q1'25
+5%
Q2'25
+17%
Q4'25
+6%
Q1'26
+7%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →No recent activity
BarclaysEqual-Weight → Underweight
Jan 6
DOWNGRADE
Bank of America Sec…Neutral
Nov 25
UPGRADE
Deutsche BankHold
Nov 15
DOWNGRADE
GuggenheimBuy → Neutral
Oct 31
DOWNGRADE
UBSNeutral
Jul 8
DOWNGRADE
BarclaysEqual-Weight
Feb 23
UPGRADE
SVB LeerinkMarket Perform
Feb 23
UPGRADE
Financials
Dividends3.47% yield
+5.3% avg annual growthAnnual Yield3.47%
Quarterly Div.$0.4300
Est. Annual / Share$1.72
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
Mondrian Investment Partners LTD
5.0M▼2
MILLER HOWARD INVESTMENTS INC /NY
1.6M▼3
Douglas Lane & Associates, LLC
1.0M▼4
BI Asset Management Fondsmaeglerselskab A/S
606K▼5
WELCH & FORBES LLC
519K—6
Foster Victor Wealth Advisors, LLC
395K▲7
Sound Income Strategies, LLC
340K▼8
KORNITZER CAPITAL MANAGEMENT INC /KS
326K▼News & Activity
GSK News
20 articles · 5h ago
This Overlooked Precious Metals ETF Offers a 7% Yield
247wallst.com
Bronstein, Gewirtz & Grossman LLC Urges Grocery Outlet Holding Corp. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges zSpace, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges monday.com Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Eos Energy Enterprises, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Trip.com Group Limited Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Alight, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ODDITY Tech Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges ChowChow Cloud International Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Fitness Champs Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges SES AI Corporation Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
Bronstein, Gewirtz & Grossman LLC Urges Gemini Space Station, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
Bronstein, Gewirtz & Grossman LLC Urges Vital Farms, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com
About
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Emma Walmsley
Country
United Kingdom
Website
Philip C. ThomsonPresident of Global Affairs
James FordSenior Vice President & Group General Counsel of Legal & Compliance
Constantin FestSenior Vice President & Head of Investor Relations
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
GSK◀ | $51.61 | -1.34% | $103.8B | 13.1 | +411.5% | 1749.8% | 1500 |
| $397.67 | +0.41% | $2.1T | 28.7 | +3296.8% | 4510.0% | 1500 | |
| $91.95 | +0.10% | $316.0B | 14.1 | +318.8% | 1510.7% | 1500 | |
| $131.46 | -0.32% | $305.1B | 22.6 | +586.3% | 1305.9% | 1500 | |
| $184.74 | -1.40% | $286.4B | 27.2 | +862.9% | 1745.9% | 1500 | |
| $146.57 | -0.87% | $279.7B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $88.98 | -1.86% | $251.9B | 14.4 | -591.0% | 668.4% | 1500 | |
| Sector avg | — | -0.76% | — | 20.1 | +783.2% | 2007.8% | 1500 |